Sergio Duran-Barragán

Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort

Sergio Duran-Barragán, Gerald McGwin, Luis M. Vilá et al. · Lara D. Veeken · 2008 · 112 citations · Full text

Tendinous and Ligamentous Derangements in Systemic Lupus Erythematosus

G Sierra-Jimenez, Adriana Sánchez-Ortíz, Francisco Javier Aceves‐Ávila et al. · The Journal of Rheumatology · 2008 · 26 citations · Full text

Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: data from North and South America, Spain and Portugal

Bernardo A. Pons‐Estel, Jorge Sánchez‐Guerrero, Juanita Romero‐Díaz et al. · Lupus · 2009 · 23 citations · Full text

Self-administered Questionnaire, Ldiq Versions, South America +16

Subclinical parameters of arterial stiffness and arteriosclerosis correlate with QRISK3 in systemic lupus erythematosus

Mónica Vázquez-Del Mercado, Felipe Pérez-Vázquez, Eduardo Gómez-Bañuelos et al. · PLoS ONE · 2018 · 20 citations · Full text

Fifteen-year trends of long-term disability and sick leaves in ankylosing spondylitis

César Ramos-Remus, G Hernandez-Rios, Sergio Duran-Barragán et al. · Clinical Rheumatology · 2011 · 16 citations

Fifteen-year Trends, Rheumatology, Spondyloarthritis +7